about
Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative DiseasesThe expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain.Lack of riluzole efficacy in the progression of the neurodegenerative phenotype in a new conditional mouse model of striatal degeneration.Neuropsychiatric Burden in Huntington's Disease.Therapeutic advances in Huntington's Disease.Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues.The Spectrum of Psychiatric Pathology in a Patient with Genetically Verified Huntington's Disease.Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.Treating psychosis in movement disorder patients: a review.Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?Cognitive interventions to enhance neural compensation in Huntington's disease.Dopamine depleters in the treatment of hyperkinetic movement disorders.Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine ModulationA Concept Map of What Helps People with HD Live with their Condition.TAK-063, a Novel Phosphodiesterase 10A Inhibitor, Protects from Striatal Neurodegeneration and Ameliorates Behavioral Deficits in the R6/2 Mouse Model of Huntington's Disease.Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.The BACHD Rat Model of Huntington Disease Shows Specific Deficits in a Test Battery of Motor Function.Revisiting the neuropsychiatry of Huntington's disease.Induced neural stem cells as a means of treatment in Huntington's disease.Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools.Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic ApproachesMetformin reverses early cortical network dysfunction and behavior changes in Huntington's disease
P2860
Q28067160-DFE56A2C-3CF4-40D8-821D-DF5D3C552895Q30838090-525BDBDA-8C01-417F-A87E-B323F1797D72Q33618095-6815BFB3-7F29-4199-8402-75D501A2D173Q33831793-56E008AB-15DE-48AF-9BA7-AB3E149C66F3Q34487604-60921972-C010-4715-88A5-F70F1EB5B52AQ34547558-EDED813D-FFF0-424A-9BA0-167300A1A051Q35738853-6CB65ED9-5882-43CE-8661-BF33785DCB89Q36106163-D9DE9F91-9D35-4980-AC28-A337D871D01AQ37652595-BCB89AE3-4F36-4988-BD58-29CF193677BDQ38213306-2FB42464-EA3E-46A1-AB0C-C6D29638B350Q38244078-FFF7E19C-3D25-4837-AC9F-FB18784A5BB1Q38430852-B8D93612-28F1-4007-A3DE-C190EFF03469Q39000590-E8D17DE3-05DE-4239-B045-5B4F6515D6B2Q39041217-DECDDDF6-B59E-4CED-9F61-381F5F49266FQ45290543-D469F190-15DB-4C22-B6D5-E93AAD2396ECQ45298693-9B01FCF3-5EDB-4547-B3C8-45D3AF6EE7C5Q45300396-D594486F-5740-4F53-BFA7-5DC68FE303A2Q45305623-EE18D4A7-C77E-4C8F-89CC-DA58F8A175BAQ45305909-63F0ED4A-2078-4944-838A-382B60E6B9CFQ47651159-EE17E242-6108-421A-B044-A0E68464702DQ48112823-5A67D972-8251-49AA-B454-C2CC47A60A1CQ52599712-A808A549-8843-4327-ABC1-F7F5A37093D2Q58737028-23A93AE4-EAD5-49B8-BD18-3D6832CAE97CQ58764354-23E4CFA9-B7D8-4F61-9958-68314348BAFB
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of Huntington's disease
@nl
Treatment of Huntington's disease.
@ast
Treatment of Huntington's disease.
@en
type
label
Treatment of Huntington's disease
@nl
Treatment of Huntington's disease.
@ast
Treatment of Huntington's disease.
@en
prefLabel
Treatment of Huntington's disease
@nl
Treatment of Huntington's disease.
@ast
Treatment of Huntington's disease.
@en
P2860
P3181
P1433
P1476
Treatment of Huntington's disease.
@en
P2093
Samuel Frank
P2860
P2888
P304
P3181
P356
10.1007/S13311-013-0244-Z
P407
P577
2014-01-01T00:00:00Z
P6179
1039653674